124 results match your criteria: "Prairie Heart Institute[Affiliation]"
Herzschrittmacherther Elektrophysiol
September 2021
Prairie Heart Institute, HSHS St. John's Hospital, 619 E Mason St, 62701, Springfield, IL, USA.
In recent decades, numerous anatomical and physiological studies of the cardiac autonomic nervous system (ANS) have investigated the complex relationships between the brain and the heart. Autonomic activation not only alters heart rate, conduction, and hemodynamics, but also cellular and subcellular properties of individual myocytes. Moreover, the cardiac ANS plays an essential role in cardiac arrhythmogenesis.
View Article and Find Full Text PDFJ Cardiovasc Electrophysiol
October 2021
Internal Medicine, Georgetown University Medical Center, Washington, District of Columbia, USA.
Background: Direct oral anticoagulants (DOACs) have increasingly been used for several indications for systemic anticoagulation in patients with cardiac implantable electronic devices (CIEDs). The optimal management of anticoagulation therapy in patients undergoing transvenous lead extraction (TLE) procedures remains uncertain.
Objectives: The aim of this study was to evaluate the feasibility and safety of TLE during minimally interrupted DOAC therapy.
Open Heart
July 2021
Division of Cardiology, Johns Hopkins University, Baltimore, Maryland, USA
Background: Most cell therapy trials failed to show an improvement in global left ventricular (LV) function measures after myocardial infarction (MI). Myocardial segments are heterogeneously impacted by MI. Global LV function indices are not able to detect the small treatment effects on segmental myocardial function which may have prognostic implications for cardiac events.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
September 2021
Department of Angiology, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.
Background: Drug coated balloon (DCB) angioplasty significantly reduces reintervention rates in patients with symptomatic femoropopliteal peripheral artery disease (PAD). However, stand-alone DCB use in long, severely calcified lesions is frequently associated with vessel recoil and/or high-grade dissections necessitating provisional stent implantation.
Objectives: Assess the safety and effectiveness of a vessel preparation strategy with directional atherectomy (DA) prior to DCB angioplasty in patients with symptomatic severely calcified femoropopliteal PAD.
JACC Cardiovasc Interv
May 2021
Department of Cardiology, Prairie Heart Institute at St. John's Hospital, Springfield, Illinois, USA. Electronic address:
J Interv Card Electrophysiol
September 2022
The Kansas City Heart Rhythm Institute & Research Foundation, Overland Park, KS, USA.
Sudden cardiac arrest (SCA) is the most common cause of death in the world. This manuscript highlights the various challenges in prevention and early management of SCA and also discusses the current state of SCA awareness. The manuscript also outlines the various national and international initiatives in improving SCA awareness and their impact on improving outcomes in SCA.
View Article and Find Full Text PDFJ Am Coll Cardiol
April 2021
Carl and Edyth Lindner Center for Research and Education, the Christ Hospital, Cincinnati, Ohio, USA. Electronic address: https://twitter.com/HenrytTimothy.
Background: The coronavirus disease 2019 (COVID-19) pandemic has impacted many aspects of ST-segment elevation myocardial infarction (STEMI) care, including timely access to primary percutaneous coronary intervention (PPCI).
Objectives: The goal of the NACMI (North American COVID-19 and STEMI) registry is to describe demographic characteristics, management strategies, and outcomes of COVID-19 patients with STEMI.
Methods: A prospective, ongoing observational registry was created under the guidance of 3 cardiology societies.
Heart Rhythm
August 2021
Division of Cardiac Electrophysiology, Prairie Heart Institute, Springfield, Illinois. Electronic address:
Background: Transvenous lead extraction (TLE) carries a significant risk of morbidity and mortality. Reliable preprocedural risk predictors to guide resource allocation and optimize procedural safety are lacking.
Objective: The aim of this study was to evaluate an intraprocedural approach to risk stratification during elective TLE procedures.
J Innov Card Rhythm Manag
March 2021
Prairie Heart Institute, Springfield, IL, USA.
In patients with inappropriate sinus tachycardia, conservative medical management targeting the relief of symptoms is the first line of therapy. Sinus node modification can offer a potential benefit in selected patients with severe, refractory inappropriate sinus tachycardia. Extensive endocardial radiofrequency (RF) ablation of the superior aspect of the sinus node complex is typically required but is often limited by the epicardial location of the sinus node and the proximity of the phrenic nerve.
View Article and Find Full Text PDFJ Cardiovasc Electrophysiol
June 2021
Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Background: Transvenous lead extraction (TLE) carries a significant risk of major complications, namely bleeding into the pericardial sac or thoracic cavity. While echocardiographic imaging has been recommended for intraprocedural monitoring for those complications, no studies had examined the potential benefits of fluoroscopy alone as an alternative to echocardiography. The aim of this study was to evaluate the utility of fluoroscopy for monitoring intrathoracic bleeding complications during TLE.
View Article and Find Full Text PDFJACC Clin Electrophysiol
January 2021
Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Objectives: This study assessed the management approach and outcome of subacute (1 to 30 days post-implantation) and delayed (>30 days) cardiac perforation by pacemaker or implantable cardioverter-defibrillator (ICD) leads.
Background: Implantation of pacemaker and ICD leads is associated with a small but serious risk of cardiac perforation. Appropriate management remains uncertain.
Cardiovasc Revasc Med
February 2021
The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH, United States of America. Electronic address:
Background: Over the past 20 years, the development of regional ST-elevation myocardial infarction (STEMI) care systems has led to remarkable progress in achieving timely coronary reperfusion with attendant improvement in clinical outcomes, including survival. Despite this progress, contemporary STEMI care does not consistently meet the national guideline-recommended goals, which offers an opportunity for further improvement in STEMI outcomes. The lack of single, comprehensive, national STEMI registry complicates our ability to improve STEMI outcomes in particular for high-risk STEMI subsets such as cardiac arrest (CA) and/or cardiogenic shock (CS).
View Article and Find Full Text PDFHeart Rhythm
September 2020
The Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address:
Background: Experience with retrieval of a Watchman left atrial (LA) appendage (LAA) closure device (WD) is limited. An embolized or grossly malpositioned WD warrants retrieval to minimize the risk of thromboembolic complications and vascular occlusion.
Objective: The purpose of this study was to report approaches for percutaneous retrieval of a WD from multicenter experience.
CJC Open
May 2020
Structural Heart Program, Prairie Heart Institute, St. John's Hospital, Springfield, Illinois, USA.
Transcatheter mitral valve repair using the MitraClip (Abbott Vascular, Santa Clara, CA) is a reasonable option for the treatment of patients with severe symptomatic degenerative mitral regurgitation (MR) who are at prohibitive surgical risk. The occurrence of recurrent severe MR after initial successful MitraClip repair is uncommon. Data are sparse on the management of recurrent severe MR after initial successful repair using the MitraClip.
View Article and Find Full Text PDFJACC Cardiovasc Interv
September 2020
Department of Cardiology, Prairie Heart Institute at HSHS St. John's Hospital, Springfield, Illinois. Electronic address:
Circulation
June 2020
Cardiovascular Division, Vanderbilt University Medical Center, Nashville, TN (J.A.B.).
Background: Paclitaxel-containing devices (PTXDs) significantly reduce reintervention in patients with symptomatic femoropopliteal peripheral artery disease. A recent aggregate-data meta-analysis reported increased late mortality in patients with peripheral artery disease treated with PTXDs. We performed an individual patient data meta-analysis to evaluate mortality.
View Article and Find Full Text PDFHeart Rhythm
September 2020
Cooper Medical School of Rowan University, Camden, New Jersey.
Coronavirus disease 2019 (COVID-19) is a global pandemic that is wreaking havoc on the health and economy of much of human civilization. Electrophysiologists have been impacted personally and professionally by this global catastrophe. In this joint article from representatives of the Heart Rhythm Society, the American College of Cardiology, and the American Heart Association, we identify the potential risks of exposure to patients, allied healthcare staff, industry representatives, and hospital administrators.
View Article and Find Full Text PDFCirculation
May 2020
Cooper Medical School of Rowan University, Camden, NJ (A.M.R.).
Coronavirus disease 2019 (COVID-19) is a global pandemic that is wreaking havoc on the health and economy of much of human civilization. Electrophysiologists have been impacted personally and professionally by this global catastrophe. In this joint article from representatives of the Heart Rhythm Society, the American College of Cardiology, and the American Heart Association, we identify the potential risks of exposure to patients, allied healthcare staff, industry representatives, and hospital administrators.
View Article and Find Full Text PDFJACC Cardiovasc Interv
December 2019
Cardiovascular Division, University of Minnesota Medical School, Minneapolis, Minnesota.
This case demonstrates the feasibility and procedural success of a novel supra-annular transcatheter mitral valve, the AltaValve via transapical approach in a patient with severe symptomatic mitral regurgitation who was a prohibitive surgical risk candidate. ().
View Article and Find Full Text PDFCatheter Cardiovasc Interv
February 2020
Metro Health-University of Michigan Health, Wyoming, Michigan.
Objectives And Background: Complex peripheral arterial disease (PAD) and critical limb ischemia (CLI) are associated with high morbidity and mortality. Endovascular techniques have become prevalent in treatment of advanced PAD and CLI, and use of techniques such as tibiopedal minimally invasive revascularization (TAMI), have been proven safe in small, single-center series. However, its use has not been systematically compared to traditional approaches.
View Article and Find Full Text PDFArch Med Sci Atheroscler Dis
November 2019
Cardiovascular Medicine Department, University of Missouri, Columbia School of Medicine, USA.
Introduction: The role of atherectomy (ATHERO) for the treatment of symptomatic infra-inguinal arterial lesions remains controversial. We evaluated the effectiveness and safety of atherectomy-assisted endovascular interventions in comparison with percutaneous angioplasty (PTA).
Material And Methods: A systematic search utilizing MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials was conducted for studies comparing ATHERO with PTA from February 1995 to May 2018.
JACC Basic Transl Sci
September 2019
Center for Arrhythmia Research, University of Michigan, Ann Arbor, Michigan.
This paper discusses the evolving concept of atrial myopathy by presenting how it develops and how it affects the properties of the atria. It also reviews the complex relationships among atrial myopathy, atrial fibrillation (AF), and stroke. Finally, it discusses how to apply the concept of atrial myopathy in the clinical setting-to identify patients with atrial myopathy and to be more selective in anticoagulation in a subset of patients with AF.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
February 2020
Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York.
Postepy Kardiol Interwencyjnej
June 2019
Division of Cardiology, University of Missouri Hospital and Clinical, Columbia, MO, USA.
Introduction: Transcatheter aortic valve replacement (TAVR) is currently considered a class I indication for patients with severe symptomatic aortic stenosis and high/prohibitive surgical risk.
Aim: We describe the effect of concomitant mitral valve regurgitation (MR) on post-procedural TAVR outcomes.
Material And Methods: The study population was extracted from the 2014 National Readmissions Data (NRD) using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for TAVR, MR and post-procedural outcomes.